Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ChemTrak Inc. To Be Listed On NASDAQ SmallCap Market.


SUNNYVALE, Calif.--(BW HealthWire)--Nov. 3, 1997--ChemTrak Inc. (Nasdaq:CMTR CMTR Certified Material Test Report
CMTR Combined Marginal Tax Rate
) announced that effective Oct. 29, 1997 its company's stock has been transferred to the Nasdaq SmallCap Market from the Nasdaq National Market.

"The SmallCap Market has proven to be an effective market for emerging growth companies such as ChemTrak. We believe that the transfer of our listing to the SmallCap Market will not materially impact our company's current plans or the ability of our shareholders to freely hold and trade our stock," said Edward F. Covell, president and chief executive officer.

Known for its leading-edge growth companies, the Nasdaq market has two tiers: the Nasdaq National Market, which lists larger companies with the most actively traded securities, and the Nasdaq SmallCap Market which lists emerging growth companies.

Located in Sunnyvale, ChemTrak is a full service medical diagnostics (1) Software routines that test hardware components (memory, keyboard, disks, etc.). Diagnostics are often stored in ROM chips and activated on startup.

(2) Error messages in a programmer's source code that refer to statements or syntax that the compiler or assembler
 company offering reliable and easy-to-use medical testing systems for in-home use and use in doctors' offices. ChemTrak medical tests are designed to screen and diagnose diagnose /di·ag·nose/ (di´ag-nos) to identify or recognize a disease.

di·ag·nose
v.
1. To distinguish or identify a disease by diagnosis.

2.
 health conditions with accuracy comparable to physician and laboratory administered tests. ChemTrak maintains a website at www.ChemTrak.com .

This statement is a forward-looking statement forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Actual results could differ from those referred to in the forward-looking statement because of certain risks and uncertainties, including the impact of state securities laws and broker solicitation solicitation

In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual
 restrictions.

CONTACT: ChemTrak Inc., Sunnyvale

Donald V. Fluken, 408/773-8156

or

Self & Associates

Trudy M. Self, 818/880-5437
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 3, 1997
Words:245
Previous Article:Diamond Multimedia Signs Agreement to Acquire Binar Graphics, Inc.; Binar President and Founder Scott D. Vouri Joins the Diamond Management Team.
Next Article:Visigenic Licenses Dominant COM/CORBA Interworking Technology From Visual Edge; Vendors Join Forces To Customize Object Bridge For Market Leading...
Topics:



Related Articles
ChemTrak reports fourth quarter and full year results.
ChemTrak files for FDA approval of home access HIV test; completes acquisition of Coonan Clinical Laboratories.
ChemTrak Inc. president resigns.
Management Changes at ChemTrak.
ChemTrak files for FDA clearance of H.pylori test.
ChemTrak announces Japanese licensing deal for technology breakthrough in asthma patient testing.
Highly accurate one-step H.pylori test cleared.
ChemTrak Inc. names controller.
ChemTrak Receives FDA Clearance to Market Point-of-Care Assay for Theophylline.
ChemTrak Signs Contract Research Pact With Pfizer Inc.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles